During the past decade, Kyoto Prefectural Yosanoumi Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kyoto Prefectural Yosanoumi Hospital" are "Carotid Artery Diseases" (1 trials), "Gastric Cancer" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Kyoto Prefectural Yosanoumi Hospital" in a lesser frequency.

Most popular intervention types in "Kyoto Prefectural Yosanoumi Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Krestin (PSK)" (1 trials), "Pitavastatin" (1 trials) and "Tegafur-gimeracil-oteracil potassium (TS-1)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kyoto Prefectural Yosanoumi Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kyoto Prefectural Yosanoumi Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kyoto Prefectural Yosanoumi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kyoto Prefectural Yosanoumi Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".